MedPath

A study on the safety and efficacy of hypofractionated radiotherapy in post-operative irradiation for breast cancer patients

Phase 2
Recruiting
Conditions
Breast cancer
Registration Number
JPRN-UMIN000010977
Lead Sponsor
ational Institute of Radiological Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Internal mammary lymph node metastasis. Residual axillary lymph node or who need to irradiate axially region. Distant metastasis. Any active collagen disease Active double primary cancer (except for carcinoma in situ and bilateral breast cancer) Concurrent chemoradiotherapy Previous chest irradiation Pregnancy and potential pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ocal recurrence-free survival rate (in radiation fields)
Secondary Outcome Measures
NameTimeMethod
Acute adverse events (the skin, subcutaneous tissue, breast tissue, and lungs) Late advese events (the skin, subcutaneous tissue, breast tissue, lungs, ribs and the heart) Cosmetic outcome
© Copyright 2025. All Rights Reserved by MedPath